Medical Care
Global Hormone Sensitive Prostate Cancer Drugs Market Research Report 2026
- Feb 24, 26
- ID: 703259
- Pages: 115
- Figures: 117
- Views: 4
This report delivers a comprehensive overview of the global Hormone Sensitive Prostate Cancer Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hormone Sensitive Prostate Cancer Drugs. The Hormone Sensitive Prostate Cancer Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hormone Sensitive Prostate Cancer Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hormone Sensitive Prostate Cancer Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novartis
Merc & Co.
Bristol-Myers
Dendreon Corporation
GlaxoSmithKline
Ferring
Roche
Celgen
Amgen
Teva
Bayer
Pfizer
Segment by Type
Androgen Ablation Therapy
Anti-androgens
Chemotherapy
Targeted Therapy
Segment by Application
Hospitals
Clinics
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Hormone Sensitive Prostate Cancer Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Hormone Sensitive Prostate Cancer Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hormone Sensitive Prostate Cancer Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novartis
Merc & Co.
Bristol-Myers
Dendreon Corporation
GlaxoSmithKline
Ferring
Roche
Celgen
Amgen
Teva
Bayer
Pfizer
Segment by Type
Androgen Ablation Therapy
Anti-androgens
Chemotherapy
Targeted Therapy
Segment by Application
Hospitals
Clinics
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Hormone Sensitive Prostate Cancer Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Androgen Ablation Therapy
1.2.3 Anti-androgens
1.2.4 Chemotherapy
1.2.5 Targeted Therapy
1.3 Market by Application
1.3.1 Global Hormone Sensitive Prostate Cancer Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hormone Sensitive Prostate Cancer Drugs Market Perspective (2021–2032)
2.2 Global Hormone Sensitive Prostate Cancer Drugs Growth Trends by Region
2.2.1 Global Hormone Sensitive Prostate Cancer Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Hormone Sensitive Prostate Cancer Drugs Historic Market Size by Region (2021–2026)
2.2.3 Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Region (2027–2032)
2.3 Hormone Sensitive Prostate Cancer Drugs Market Dynamics
2.3.1 Hormone Sensitive Prostate Cancer Drugs Industry Trends
2.3.2 Hormone Sensitive Prostate Cancer Drugs Market Drivers
2.3.3 Hormone Sensitive Prostate Cancer Drugs Market Challenges
2.3.4 Hormone Sensitive Prostate Cancer Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hormone Sensitive Prostate Cancer Drugs Players by Revenue
3.1.1 Global Top Hormone Sensitive Prostate Cancer Drugs Players by Revenue (2021–2026)
3.1.2 Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top Hormone Sensitive Prostate Cancer Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Hormone Sensitive Prostate Cancer Drugs Revenue
3.4 Global Hormone Sensitive Prostate Cancer Drugs Market Concentration Ratio
3.4.1 Global Hormone Sensitive Prostate Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hormone Sensitive Prostate Cancer Drugs Revenue in 2025
3.5 Global Key Players of Hormone Sensitive Prostate Cancer Drugs Head Offices and Areas Served
3.6 Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Products and Applications
3.7 Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Hormone Sensitive Prostate Cancer Drugs Breakdown Data by Type
4.1 Global Hormone Sensitive Prostate Cancer Drugs Historic Market Size by Type (2021–2026)
4.2 Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Type (2027–2032)
5 Hormone Sensitive Prostate Cancer Drugs Breakdown Data by Application
5.1 Global Hormone Sensitive Prostate Cancer Drugs Historic Market Size by Application (2021–2026)
5.2 Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)
6.2 North America Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021–2026)
6.4 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)
7.2 Europe Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021–2026)
7.4 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)
8.2 Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)
9.2 Latin America Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021–2026)
9.4 Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)
10.2 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Hormone Sensitive Prostate Cancer Drugs Introduction
11.1.4 Novartis Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.1.5 Novartis Recent Development
11.2 Merc & Co.
11.2.1 Merc & Co. Company Details
11.2.2 Merc & Co. Business Overview
11.2.3 Merc & Co. Hormone Sensitive Prostate Cancer Drugs Introduction
11.2.4 Merc & Co. Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.2.5 Merc & Co. Recent Development
11.3 Bristol-Myers
11.3.1 Bristol-Myers Company Details
11.3.2 Bristol-Myers Business Overview
11.3.3 Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Introduction
11.3.4 Bristol-Myers Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.3.5 Bristol-Myers Recent Development
11.4 Dendreon Corporation
11.4.1 Dendreon Corporation Company Details
11.4.2 Dendreon Corporation Business Overview
11.4.3 Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Introduction
11.4.4 Dendreon Corporation Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.4.5 Dendreon Corporation Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.5.5 GlaxoSmithKline Recent Development
11.6 Ferring
11.6.1 Ferring Company Details
11.6.2 Ferring Business Overview
11.6.3 Ferring Hormone Sensitive Prostate Cancer Drugs Introduction
11.6.4 Ferring Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.6.5 Ferring Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Hormone Sensitive Prostate Cancer Drugs Introduction
11.7.4 Roche Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.7.5 Roche Recent Development
11.8 Celgen
11.8.1 Celgen Company Details
11.8.2 Celgen Business Overview
11.8.3 Celgen Hormone Sensitive Prostate Cancer Drugs Introduction
11.8.4 Celgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.8.5 Celgen Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Hormone Sensitive Prostate Cancer Drugs Introduction
11.9.4 Amgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.9.5 Amgen Recent Development
11.10 Teva
11.10.1 Teva Company Details
11.10.2 Teva Business Overview
11.10.3 Teva Hormone Sensitive Prostate Cancer Drugs Introduction
11.10.4 Teva Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.10.5 Teva Recent Development
11.11 Bayer
11.11.1 Bayer Company Details
11.11.2 Bayer Business Overview
11.11.3 Bayer Hormone Sensitive Prostate Cancer Drugs Introduction
11.11.4 Bayer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.11.5 Bayer Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Hormone Sensitive Prostate Cancer Drugs Introduction
11.12.4 Pfizer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.12.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Androgen Ablation Therapy
1.2.3 Anti-androgens
1.2.4 Chemotherapy
1.2.5 Targeted Therapy
1.3 Market by Application
1.3.1 Global Hormone Sensitive Prostate Cancer Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hormone Sensitive Prostate Cancer Drugs Market Perspective (2021–2032)
2.2 Global Hormone Sensitive Prostate Cancer Drugs Growth Trends by Region
2.2.1 Global Hormone Sensitive Prostate Cancer Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Hormone Sensitive Prostate Cancer Drugs Historic Market Size by Region (2021–2026)
2.2.3 Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Region (2027–2032)
2.3 Hormone Sensitive Prostate Cancer Drugs Market Dynamics
2.3.1 Hormone Sensitive Prostate Cancer Drugs Industry Trends
2.3.2 Hormone Sensitive Prostate Cancer Drugs Market Drivers
2.3.3 Hormone Sensitive Prostate Cancer Drugs Market Challenges
2.3.4 Hormone Sensitive Prostate Cancer Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hormone Sensitive Prostate Cancer Drugs Players by Revenue
3.1.1 Global Top Hormone Sensitive Prostate Cancer Drugs Players by Revenue (2021–2026)
3.1.2 Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top Hormone Sensitive Prostate Cancer Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Hormone Sensitive Prostate Cancer Drugs Revenue
3.4 Global Hormone Sensitive Prostate Cancer Drugs Market Concentration Ratio
3.4.1 Global Hormone Sensitive Prostate Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hormone Sensitive Prostate Cancer Drugs Revenue in 2025
3.5 Global Key Players of Hormone Sensitive Prostate Cancer Drugs Head Offices and Areas Served
3.6 Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Products and Applications
3.7 Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Hormone Sensitive Prostate Cancer Drugs Breakdown Data by Type
4.1 Global Hormone Sensitive Prostate Cancer Drugs Historic Market Size by Type (2021–2026)
4.2 Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Type (2027–2032)
5 Hormone Sensitive Prostate Cancer Drugs Breakdown Data by Application
5.1 Global Hormone Sensitive Prostate Cancer Drugs Historic Market Size by Application (2021–2026)
5.2 Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)
6.2 North America Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021–2026)
6.4 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)
7.2 Europe Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021–2026)
7.4 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)
8.2 Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)
9.2 Latin America Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021–2026)
9.4 Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size (2021–2032)
10.2 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Hormone Sensitive Prostate Cancer Drugs Introduction
11.1.4 Novartis Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.1.5 Novartis Recent Development
11.2 Merc & Co.
11.2.1 Merc & Co. Company Details
11.2.2 Merc & Co. Business Overview
11.2.3 Merc & Co. Hormone Sensitive Prostate Cancer Drugs Introduction
11.2.4 Merc & Co. Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.2.5 Merc & Co. Recent Development
11.3 Bristol-Myers
11.3.1 Bristol-Myers Company Details
11.3.2 Bristol-Myers Business Overview
11.3.3 Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Introduction
11.3.4 Bristol-Myers Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.3.5 Bristol-Myers Recent Development
11.4 Dendreon Corporation
11.4.1 Dendreon Corporation Company Details
11.4.2 Dendreon Corporation Business Overview
11.4.3 Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Introduction
11.4.4 Dendreon Corporation Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.4.5 Dendreon Corporation Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.5.5 GlaxoSmithKline Recent Development
11.6 Ferring
11.6.1 Ferring Company Details
11.6.2 Ferring Business Overview
11.6.3 Ferring Hormone Sensitive Prostate Cancer Drugs Introduction
11.6.4 Ferring Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.6.5 Ferring Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Hormone Sensitive Prostate Cancer Drugs Introduction
11.7.4 Roche Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.7.5 Roche Recent Development
11.8 Celgen
11.8.1 Celgen Company Details
11.8.2 Celgen Business Overview
11.8.3 Celgen Hormone Sensitive Prostate Cancer Drugs Introduction
11.8.4 Celgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.8.5 Celgen Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Hormone Sensitive Prostate Cancer Drugs Introduction
11.9.4 Amgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.9.5 Amgen Recent Development
11.10 Teva
11.10.1 Teva Company Details
11.10.2 Teva Business Overview
11.10.3 Teva Hormone Sensitive Prostate Cancer Drugs Introduction
11.10.4 Teva Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.10.5 Teva Recent Development
11.11 Bayer
11.11.1 Bayer Company Details
11.11.2 Bayer Business Overview
11.11.3 Bayer Hormone Sensitive Prostate Cancer Drugs Introduction
11.11.4 Bayer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.11.5 Bayer Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Hormone Sensitive Prostate Cancer Drugs Introduction
11.12.4 Pfizer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
11.12.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Androgen Ablation Therapy
Table 3. Key Players of Anti-androgens
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Targeted Therapy
Table 6. Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Region (US$ Million), 2021–2026
Table 9. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Region (2021–2026)
Table 10. Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Region (2027–2032)
Table 12. Hormone Sensitive Prostate Cancer Drugs Market Trends
Table 13. Hormone Sensitive Prostate Cancer Drugs Market Drivers
Table 14. Hormone Sensitive Prostate Cancer Drugs Market Challenges
Table 15. Hormone Sensitive Prostate Cancer Drugs Market Restraints
Table 16. Global Hormone Sensitive Prostate Cancer Drugs Revenue by Players (US$ Million), 2021–2026
Table 17. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Players (2021–2026)
Table 18. Global Top Hormone Sensitive Prostate Cancer Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Hormone Sensitive Prostate Cancer Drugs Revenue, 2025
Table 19. Ranking of Global Top Hormone Sensitive Prostate Cancer Drugs Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Hormone Sensitive Prostate Cancer Drugs Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Headquarters and Area Served
Table 22. Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Products and Applications
Table 23. Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Type (US$ Million), 2021–2026
Table 26. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Type (2021–2026)
Table 27. Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Type (2027–2032)
Table 29. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Application (US$ Million), 2021–2026
Table 30. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Application (2021–2026)
Table 31. Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Application (2027–2032)
Table 33. North America Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2021–2026
Table 35. North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2027–2032
Table 48. Novartis Company Details
Table 49. Novartis Business Overview
Table 50. Novartis Hormone Sensitive Prostate Cancer Drugs Product
Table 51. Novartis Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 52. Novartis Recent Development
Table 53. Merc & Co. Company Details
Table 54. Merc & Co. Business Overview
Table 55. Merc & Co. Hormone Sensitive Prostate Cancer Drugs Product
Table 56. Merc & Co. Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 57. Merc & Co. Recent Development
Table 58. Bristol-Myers Company Details
Table 59. Bristol-Myers Business Overview
Table 60. Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Product
Table 61. Bristol-Myers Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 62. Bristol-Myers Recent Development
Table 63. Dendreon Corporation Company Details
Table 64. Dendreon Corporation Business Overview
Table 65. Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Product
Table 66. Dendreon Corporation Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 67. Dendreon Corporation Recent Development
Table 68. GlaxoSmithKline Company Details
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Product
Table 71. GlaxoSmithKline Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 72. GlaxoSmithKline Recent Development
Table 73. Ferring Company Details
Table 74. Ferring Business Overview
Table 75. Ferring Hormone Sensitive Prostate Cancer Drugs Product
Table 76. Ferring Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 77. Ferring Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Hormone Sensitive Prostate Cancer Drugs Product
Table 81. Roche Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 82. Roche Recent Development
Table 83. Celgen Company Details
Table 84. Celgen Business Overview
Table 85. Celgen Hormone Sensitive Prostate Cancer Drugs Product
Table 86. Celgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 87. Celgen Recent Development
Table 88. Amgen Company Details
Table 89. Amgen Business Overview
Table 90. Amgen Hormone Sensitive Prostate Cancer Drugs Product
Table 91. Amgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 92. Amgen Recent Development
Table 93. Teva Company Details
Table 94. Teva Business Overview
Table 95. Teva Hormone Sensitive Prostate Cancer Drugs Product
Table 96. Teva Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 97. Teva Recent Development
Table 98. Bayer Company Details
Table 99. Bayer Business Overview
Table 100. Bayer Hormone Sensitive Prostate Cancer Drugs Product
Table 101. Bayer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 102. Bayer Recent Development
Table 103. Pfizer Company Details
Table 104. Pfizer Business Overview
Table 105. Pfizer Hormone Sensitive Prostate Cancer Drugs Product
Table 106. Pfizer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 107. Pfizer Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Hormone Sensitive Prostate Cancer Drugs Picture
Figure 2. Global Hormone Sensitive Prostate Cancer Drugs Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Type: 2025 vs 2032
Figure 4. Androgen Ablation Therapy Features
Figure 5. Anti-androgens Features
Figure 6. Chemotherapy Features
Figure 7. Targeted Therapy Features
Figure 8. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Application: 2025 vs 2032
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Other Case Studies
Figure 13. Hormone Sensitive Prostate Cancer Drugs Report Years Considered
Figure 14. Global Hormone Sensitive Prostate Cancer Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Hormone Sensitive Prostate Cancer Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Region: 2025 vs 2032
Figure 17. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Players in 2025
Figure 18. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Hormone Sensitive Prostate Cancer Drugs Revenue in 2025
Figure 20. North America Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2021–2032)
Figure 22. United States Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2021–2032)
Figure 26. Germany Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Share by Region (2021–2032)
Figure 34. China Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2021–2032)
Figure 42. Mexico Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2021–2032)
Figure 46. Israel Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Novartis Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 50. Merc & Co. Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 51. Bristol-Myers Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 52. Dendreon Corporation Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 54. Ferring Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 55. Roche Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 56. Celgen Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 57. Amgen Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 58. Teva Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 59. Bayer Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 60. Pfizer Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Androgen Ablation Therapy
Table 3. Key Players of Anti-androgens
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Targeted Therapy
Table 6. Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Region (US$ Million), 2021–2026
Table 9. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Region (2021–2026)
Table 10. Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Region (2027–2032)
Table 12. Hormone Sensitive Prostate Cancer Drugs Market Trends
Table 13. Hormone Sensitive Prostate Cancer Drugs Market Drivers
Table 14. Hormone Sensitive Prostate Cancer Drugs Market Challenges
Table 15. Hormone Sensitive Prostate Cancer Drugs Market Restraints
Table 16. Global Hormone Sensitive Prostate Cancer Drugs Revenue by Players (US$ Million), 2021–2026
Table 17. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Players (2021–2026)
Table 18. Global Top Hormone Sensitive Prostate Cancer Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Hormone Sensitive Prostate Cancer Drugs Revenue, 2025
Table 19. Ranking of Global Top Hormone Sensitive Prostate Cancer Drugs Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Hormone Sensitive Prostate Cancer Drugs Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Headquarters and Area Served
Table 22. Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Products and Applications
Table 23. Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Type (US$ Million), 2021–2026
Table 26. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Type (2021–2026)
Table 27. Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Type (2027–2032)
Table 29. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Application (US$ Million), 2021–2026
Table 30. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Application (2021–2026)
Table 31. Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Application (2027–2032)
Table 33. North America Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2021–2026
Table 35. North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Country (US$ Million), 2027–2032
Table 48. Novartis Company Details
Table 49. Novartis Business Overview
Table 50. Novartis Hormone Sensitive Prostate Cancer Drugs Product
Table 51. Novartis Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 52. Novartis Recent Development
Table 53. Merc & Co. Company Details
Table 54. Merc & Co. Business Overview
Table 55. Merc & Co. Hormone Sensitive Prostate Cancer Drugs Product
Table 56. Merc & Co. Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 57. Merc & Co. Recent Development
Table 58. Bristol-Myers Company Details
Table 59. Bristol-Myers Business Overview
Table 60. Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Product
Table 61. Bristol-Myers Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 62. Bristol-Myers Recent Development
Table 63. Dendreon Corporation Company Details
Table 64. Dendreon Corporation Business Overview
Table 65. Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Product
Table 66. Dendreon Corporation Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 67. Dendreon Corporation Recent Development
Table 68. GlaxoSmithKline Company Details
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Product
Table 71. GlaxoSmithKline Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 72. GlaxoSmithKline Recent Development
Table 73. Ferring Company Details
Table 74. Ferring Business Overview
Table 75. Ferring Hormone Sensitive Prostate Cancer Drugs Product
Table 76. Ferring Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 77. Ferring Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Hormone Sensitive Prostate Cancer Drugs Product
Table 81. Roche Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 82. Roche Recent Development
Table 83. Celgen Company Details
Table 84. Celgen Business Overview
Table 85. Celgen Hormone Sensitive Prostate Cancer Drugs Product
Table 86. Celgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 87. Celgen Recent Development
Table 88. Amgen Company Details
Table 89. Amgen Business Overview
Table 90. Amgen Hormone Sensitive Prostate Cancer Drugs Product
Table 91. Amgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 92. Amgen Recent Development
Table 93. Teva Company Details
Table 94. Teva Business Overview
Table 95. Teva Hormone Sensitive Prostate Cancer Drugs Product
Table 96. Teva Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 97. Teva Recent Development
Table 98. Bayer Company Details
Table 99. Bayer Business Overview
Table 100. Bayer Hormone Sensitive Prostate Cancer Drugs Product
Table 101. Bayer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 102. Bayer Recent Development
Table 103. Pfizer Company Details
Table 104. Pfizer Business Overview
Table 105. Pfizer Hormone Sensitive Prostate Cancer Drugs Product
Table 106. Pfizer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (US$ Million), 2021–2026
Table 107. Pfizer Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Hormone Sensitive Prostate Cancer Drugs Picture
Figure 2. Global Hormone Sensitive Prostate Cancer Drugs Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Type: 2025 vs 2032
Figure 4. Androgen Ablation Therapy Features
Figure 5. Anti-androgens Features
Figure 6. Chemotherapy Features
Figure 7. Targeted Therapy Features
Figure 8. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Application: 2025 vs 2032
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Other Case Studies
Figure 13. Hormone Sensitive Prostate Cancer Drugs Report Years Considered
Figure 14. Global Hormone Sensitive Prostate Cancer Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Hormone Sensitive Prostate Cancer Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Region: 2025 vs 2032
Figure 17. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Players in 2025
Figure 18. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Hormone Sensitive Prostate Cancer Drugs Revenue in 2025
Figure 20. North America Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2021–2032)
Figure 22. United States Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2021–2032)
Figure 26. Germany Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Hormone Sensitive Prostate Cancer Drugs Market Share by Region (2021–2032)
Figure 34. China Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2021–2032)
Figure 42. Mexico Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2021–2032)
Figure 46. Israel Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Novartis Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 50. Merc & Co. Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 51. Bristol-Myers Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 52. Dendreon Corporation Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 54. Ferring Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 55. Roche Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 56. Celgen Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 57. Amgen Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 58. Teva Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 59. Bayer Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 60. Pfizer Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232